Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.695
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
13f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.765
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
13f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0520
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
55f:40m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
13f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.503
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
13f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0482
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
13f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.983
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00149
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000351
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.173
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.354
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.341
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00518
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.650
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.679
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.686
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00299
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.446
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.164
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.534
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.150
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.847
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0407
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.199
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
5.19×10-05
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.486
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00875
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.833
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
3.46×10-05
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.499
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HOM
|
11f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
3.02×10-05
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat mass
|
HOM
|
11f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.483
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
9f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.821
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.972
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HOM
|
753f:718m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
8f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.176
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.787
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HOM
|
753f:718m
|
|
|
NotProcessed |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.127
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0128
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HOM
|
11f:8m
|
|
|
NotProcessed |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0375
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.928
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000624
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0158
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00215
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0202
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.347
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.319
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.658
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.157
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0178
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.571
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.318
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.508
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.302
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.640
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0186
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.415
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.120
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.487
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.152
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.486
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.302
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
10f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.883
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.302
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.564
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.214
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
10f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.344
|
Successful |
Pbx3tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
11f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.848
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00167
|
Successful |
Pbx3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
5.78×10-05
|
Successful |